 Laurel Lenz
Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Listeria monocytogenes | 30 | 2021 | 123 | 7.330 |
Why?
| | Listeriosis | 20 | 2021 | 67 | 5.170 |
Why?
| | Killer Cells, Natural | 12 | 2021 | 426 | 3.080 |
Why?
| | Interferon-gamma | 12 | 2019 | 772 | 2.400 |
Why?
| | Interleukin-10 | 5 | 2021 | 300 | 2.260 |
Why?
| | Receptors, Interferon | 8 | 2019 | 50 | 2.020 |
Why?
| | Myeloid Cells | 5 | 2020 | 142 | 1.960 |
Why?
| | Interferon Type I | 7 | 2019 | 139 | 1.610 |
Why?
| | Macrophages | 12 | 2020 | 1488 | 1.470 |
Why?
| | Interleukin-18 | 4 | 2018 | 237 | 1.270 |
Why?
| | Streptococcus pneumoniae | 2 | 2020 | 161 | 1.190 |
Why?
| | Dendritic Cells | 9 | 2018 | 481 | 1.110 |
Why?
| | Immunity, Innate | 12 | 2021 | 805 | 1.070 |
Why?
| | Bacterial Infections | 4 | 2018 | 235 | 1.010 |
Why?
| | Bacterial Proteins | 9 | 2018 | 836 | 1.010 |
Why?
| | Interferon-beta | 3 | 2018 | 89 | 0.990 |
Why?
| | Host-Pathogen Interactions | 3 | 2020 | 356 | 0.900 |
Why?
| | Interferon-alpha | 2 | 2018 | 194 | 0.850 |
Why?
| | Mice, Inbred C57BL | 21 | 2021 | 5455 | 0.830 |
Why?
| | Animals | 52 | 2022 | 35391 | 0.820 |
Why?
| | Repressor Proteins | 2 | 2018 | 406 | 0.800 |
Why?
| | Mice | 41 | 2022 | 16961 | 0.800 |
Why?
| | STAT3 Transcription Factor | 3 | 2022 | 194 | 0.770 |
Why?
| | Mice, Knockout | 15 | 2021 | 2881 | 0.770 |
Why?
| | Leukocytes, Mononuclear | 2 | 2025 | 546 | 0.720 |
Why?
| | Interleukin-15 | 2 | 2019 | 83 | 0.710 |
Why?
| | Casein Kinase II | 1 | 2020 | 21 | 0.710 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2020 | 42 | 0.650 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 3 | 2009 | 5 | 0.640 |
Why?
| | Orthomyxoviridae Infections | 1 | 2020 | 67 | 0.640 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2018 | 149 | 0.630 |
Why?
| | Influenza A virus | 1 | 2020 | 100 | 0.620 |
Why?
| | Bacteria | 3 | 2018 | 814 | 0.620 |
Why?
| | Lymphocyte Activation | 4 | 2016 | 1109 | 0.620 |
Why?
| | Pneumococcal Infections | 1 | 2020 | 112 | 0.610 |
Why?
| | Coinfection | 1 | 2020 | 131 | 0.600 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 41 | 0.590 |
Why?
| | Streptococcal Infections | 1 | 2020 | 148 | 0.590 |
Why?
| | Macrophage Activation | 4 | 2017 | 189 | 0.580 |
Why?
| | Disease Susceptibility | 4 | 2021 | 334 | 0.540 |
Why?
| | Flow Cytometry | 4 | 2016 | 1159 | 0.480 |
Why?
| | Pneumonia | 1 | 2021 | 617 | 0.480 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 340 | 0.470 |
Why?
| | Bacterial Vaccines | 2 | 2020 | 63 | 0.460 |
Why?
| | Adenosine Triphosphatases | 3 | 2007 | 161 | 0.450 |
Why?
| | T-Lymphocytes, Cytotoxic | 6 | 2007 | 170 | 0.440 |
Why?
| | Early Growth Response Protein 3 | 1 | 2013 | 1 | 0.430 |
Why?
| | Influenza, Human | 1 | 2020 | 601 | 0.430 |
Why?
| | Lung Diseases | 1 | 2020 | 741 | 0.430 |
Why?
| | Interferon Regulatory Factor-3 | 3 | 2011 | 17 | 0.420 |
Why?
| | Antigens, Bacterial | 4 | 1998 | 119 | 0.420 |
Why?
| | Toll-Like Receptors | 3 | 2012 | 179 | 0.390 |
Why?
| | Gene Silencing | 1 | 2013 | 190 | 0.390 |
Why?
| | H-2 Antigens | 3 | 1997 | 115 | 0.390 |
Why?
| | Anthrax | 1 | 2012 | 9 | 0.390 |
Why?
| | Bacillus anthracis | 1 | 2012 | 12 | 0.390 |
Why?
| | Gene Expression | 3 | 2019 | 1465 | 0.390 |
Why?
| | Lymph Nodes | 2 | 2012 | 472 | 0.380 |
Why?
| | Membrane Transport Proteins | 2 | 2003 | 149 | 0.380 |
Why?
| | Membrane Proteins | 5 | 2021 | 1125 | 0.370 |
Why?
| | Lung | 3 | 2019 | 3938 | 0.370 |
Why?
| | Escherichia coli Proteins | 2 | 2003 | 179 | 0.360 |
Why?
| | Cyclic GMP | 1 | 2011 | 90 | 0.360 |
Why?
| | Peptidoglycan | 2 | 2009 | 23 | 0.360 |
Why?
| | Inflammasomes | 1 | 2012 | 126 | 0.360 |
Why?
| | Cyclic AMP | 1 | 2011 | 238 | 0.340 |
Why?
| | Interleukin-1beta | 1 | 2012 | 372 | 0.340 |
Why?
| | Cells, Cultured | 6 | 2019 | 4084 | 0.330 |
Why?
| | Recombinant Proteins | 3 | 2011 | 1308 | 0.330 |
Why?
| | Down-Regulation | 5 | 2019 | 636 | 0.320 |
Why?
| | Antigens | 1 | 2011 | 356 | 0.310 |
Why?
| | CD5 Antigens | 1 | 2009 | 10 | 0.310 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2128 | 0.310 |
Why?
| | Mice, Inbred BALB C | 9 | 2012 | 1250 | 0.310 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 242 | 0.310 |
Why?
| | Bone Marrow Cells | 3 | 2010 | 302 | 0.300 |
Why?
| | Cell Communication | 1 | 2010 | 301 | 0.290 |
Why?
| | Lymphocytes | 2 | 2014 | 378 | 0.290 |
Why?
| | Recombination, Genetic | 1 | 2008 | 190 | 0.280 |
Why?
| | Antigen Presentation | 3 | 1998 | 207 | 0.270 |
Why?
| | Genetic Vectors | 1 | 2008 | 314 | 0.270 |
Why?
| | Nitric Oxide | 1 | 2012 | 895 | 0.270 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 877 | 0.260 |
Why?
| | Host-Parasite Interactions | 1 | 2007 | 103 | 0.260 |
Why?
| | Genes, Bacterial | 2 | 2008 | 157 | 0.260 |
Why?
| | B-Lymphocytes | 1 | 2012 | 816 | 0.260 |
Why?
| | Selection, Genetic | 1 | 2008 | 251 | 0.260 |
Why?
| | Head and Neck Neoplasms | 2 | 2021 | 544 | 0.260 |
Why?
| | Coculture Techniques | 3 | 2025 | 223 | 0.260 |
Why?
| | Communicable Diseases | 1 | 2007 | 152 | 0.240 |
Why?
| | Virulence | 5 | 2008 | 255 | 0.240 |
Why?
| | Cytokines | 6 | 2025 | 2021 | 0.230 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2025 | 52 | 0.230 |
Why?
| | Epitopes | 2 | 1997 | 472 | 0.230 |
Why?
| | Inflammation | 3 | 2020 | 2750 | 0.230 |
Why?
| | Female | 17 | 2021 | 68735 | 0.230 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2025 | 69 | 0.220 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2003 | 220 | 0.210 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 120 | 0.210 |
Why?
| | Cell Line | 5 | 2012 | 2784 | 0.200 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4078 | 0.190 |
Why?
| | Radioimmunotherapy | 1 | 2021 | 16 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 834 | 0.180 |
Why?
| | Ligands | 4 | 2019 | 621 | 0.180 |
Why?
| | Male | 11 | 2025 | 63671 | 0.180 |
Why?
| | Mouth Diseases | 1 | 2021 | 43 | 0.180 |
Why?
| | Vaccinia | 1 | 2000 | 21 | 0.180 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2000 | 14 | 0.180 |
Why?
| | Humans | 20 | 2025 | 129627 | 0.170 |
Why?
| | Respiratory Tract Infections | 1 | 2025 | 376 | 0.170 |
Why?
| | Transcription, Genetic | 2 | 2019 | 1418 | 0.170 |
Why?
| | Antigen-Presenting Cells | 1 | 2000 | 151 | 0.170 |
Why?
| | Legionnaires' Disease | 1 | 2019 | 4 | 0.170 |
Why?
| | Legionella pneumophila | 1 | 2019 | 3 | 0.170 |
Why?
| | Bites and Stings | 1 | 2020 | 32 | 0.160 |
Why?
| | Malaria, Cerebral | 1 | 2019 | 4 | 0.160 |
Why?
| | Amino Acid Sequence | 6 | 2009 | 2057 | 0.160 |
Why?
| | Signal Transduction | 6 | 2019 | 4931 | 0.160 |
Why?
| | CD4 Antigens | 1 | 2019 | 137 | 0.160 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2022 | 269 | 0.150 |
Why?
| | STAT4 Transcription Factor | 1 | 2018 | 4 | 0.150 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 176 | 0.150 |
Why?
| | Solubility | 1 | 2018 | 232 | 0.140 |
Why?
| | Disease Progression | 2 | 2022 | 2627 | 0.130 |
Why?
| | Interleukin-2 | 1 | 2018 | 437 | 0.130 |
Why?
| | Monocytes | 1 | 2019 | 553 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 389 | 0.130 |
Why?
| | Survival Analysis | 1 | 2019 | 1269 | 0.130 |
Why?
| | Blotting, Western | 2 | 2013 | 1206 | 0.130 |
Why?
| | Chromatin | 1 | 2019 | 479 | 0.120 |
Why?
| | NF-kappa B | 1 | 2019 | 665 | 0.120 |
Why?
| | Adoptive Transfer | 1 | 2016 | 218 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 260 | 0.120 |
Why?
| | Phosphorylation | 2 | 2010 | 1713 | 0.120 |
Why?
| | Adenocarcinoma | 1 | 2022 | 893 | 0.120 |
Why?
| | Genotype | 1 | 2020 | 1833 | 0.120 |
Why?
| | Breeding | 1 | 2014 | 62 | 0.110 |
Why?
| | Housing, Animal | 1 | 2014 | 46 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2022 | 880 | 0.110 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 86 | 0.110 |
Why?
| | SEC Translocation Channels | 2 | 2003 | 10 | 0.100 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 132 | 0.100 |
Why?
| | T-Lymphocyte Subsets | 2 | 2007 | 412 | 0.100 |
Why?
| | Interleukin-12 | 3 | 2011 | 118 | 0.100 |
Why?
| | Caspases, Initiator | 1 | 2012 | 17 | 0.100 |
Why?
| | Molecular Sequence Data | 5 | 2004 | 2835 | 0.100 |
Why?
| | Infant | 3 | 2025 | 8995 | 0.100 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 593 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 329 | 0.100 |
Why?
| | Spores, Bacterial | 1 | 2012 | 18 | 0.100 |
Why?
| | Receptors, CCR7 | 1 | 2012 | 28 | 0.100 |
Why?
| | Phagosomes | 1 | 2012 | 42 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2010 | 97 | 0.100 |
Why?
| | Caspase 1 | 1 | 2012 | 143 | 0.100 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2012 | 171 | 0.090 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 134 | 0.090 |
Why?
| | Immunologic Factors | 1 | 2013 | 230 | 0.090 |
Why?
| | Receptors, Complement | 1 | 2012 | 122 | 0.090 |
Why?
| | Instillation, Drug | 1 | 2011 | 9 | 0.090 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 126 | 0.090 |
Why?
| | Caspases | 1 | 2012 | 245 | 0.090 |
Why?
| | Francisella tularensis | 1 | 2011 | 30 | 0.090 |
Why?
| | Immunotherapy | 1 | 2016 | 596 | 0.090 |
Why?
| | Vesiculovirus | 1 | 2011 | 16 | 0.090 |
Why?
| | Adaptive Immunity | 1 | 2012 | 161 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 640 | 0.090 |
Why?
| | Cell Death | 1 | 2012 | 354 | 0.090 |
Why?
| | Phagocytes | 1 | 2011 | 97 | 0.090 |
Why?
| | Immunoglobulin M | 1 | 2012 | 276 | 0.090 |
Why?
| | TRPM Cation Channels | 1 | 2011 | 77 | 0.090 |
Why?
| | STAT1 Transcription Factor | 1 | 2010 | 69 | 0.080 |
Why?
| | Immunologic Memory | 2 | 2007 | 349 | 0.080 |
Why?
| | Melanoma, Experimental | 1 | 2011 | 107 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 2 | 2007 | 113 | 0.080 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2003 | 200 | 0.080 |
Why?
| | Base Sequence | 4 | 2004 | 2147 | 0.080 |
Why?
| | Gene Deletion | 2 | 2008 | 382 | 0.080 |
Why?
| | Spleen | 2 | 2008 | 509 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 949 | 0.080 |
Why?
| | Receptors, Cell Surface | 2 | 2009 | 381 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2022 | 373 | 0.080 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2013 | 353 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 363 | 0.080 |
Why?
| | Alanine Racemase | 1 | 2008 | 2 | 0.080 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2008 | 7 | 0.080 |
Why?
| | Genetic Complementation Test | 1 | 2008 | 63 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2012 | 745 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2008 | 855 | 0.070 |
Why?
| | AIDS Vaccines | 1 | 2008 | 47 | 0.070 |
Why?
| | Vaccines, Attenuated | 1 | 2008 | 125 | 0.070 |
Why?
| | Liver | 3 | 2018 | 1842 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 1 | 2007 | 47 | 0.070 |
Why?
| | Hemolysin Proteins | 1 | 2007 | 34 | 0.070 |
Why?
| | Mutation | 4 | 2010 | 3717 | 0.070 |
Why?
| | Immunotherapy, Adoptive | 1 | 2011 | 300 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2007 | 92 | 0.070 |
Why?
| | Tumor Microenvironment | 2 | 2021 | 627 | 0.070 |
Why?
| | Plasmids | 1 | 2008 | 359 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 2007 | 104 | 0.070 |
Why?
| | Bystander Effect | 1 | 2007 | 15 | 0.070 |
Why?
| | Heat-Shock Proteins | 1 | 2007 | 136 | 0.070 |
Why?
| | Biological Transport | 1 | 2007 | 404 | 0.070 |
Why?
| | Fungi | 1 | 2007 | 136 | 0.060 |
Why?
| | Virulence Factors | 1 | 2007 | 157 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 843 | 0.060 |
Why?
| | Autoantibodies | 1 | 2013 | 1468 | 0.060 |
Why?
| | Antibodies | 1 | 2007 | 398 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 2882 | 0.060 |
Why?
| | Alleles | 2 | 2020 | 847 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 58 | 0.060 |
Why?
| | A549 Cells | 1 | 2025 | 59 | 0.060 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 323 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 161 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2007 | 1058 | 0.060 |
Why?
| | Autolysis | 1 | 2003 | 3 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1687 | 0.050 |
Why?
| | Immunity, Cellular | 1 | 2025 | 265 | 0.050 |
Why?
| | Aged | 2 | 2020 | 22061 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2007 | 723 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 372 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2007 | 1936 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2002 | 525 | 0.050 |
Why?
| | DNA Primers | 1 | 2002 | 511 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2455 | 0.050 |
Why?
| | Nucleoproteins | 1 | 2000 | 28 | 0.040 |
Why?
| | Chimera | 1 | 2000 | 60 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2000 | 24 | 0.040 |
Why?
| | Vaccinia virus | 1 | 2000 | 42 | 0.040 |
Why?
| | Cell Movement | 1 | 2005 | 948 | 0.040 |
Why?
| | Nucleotides, Cyclic | 1 | 2020 | 16 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2020 | 53 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 953 | 0.040 |
Why?
| | Major Histocompatibility Complex | 1 | 2000 | 230 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 57 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 79 | 0.040 |
Why?
| | Phenotype | 2 | 2005 | 3075 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 195 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 169 | 0.030 |
Why?
| | Proteomics | 1 | 2003 | 1055 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 637 | 0.030 |
Why?
| | Transformation, Bacterial | 1 | 1996 | 6 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 115 | 0.030 |
Why?
| | Feces | 1 | 2018 | 442 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 6417 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 504 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 590 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2025 | 5756 | 0.030 |
Why?
| | Rituximab | 1 | 2013 | 164 | 0.030 |
Why?
| | Parrots | 1 | 1992 | 1 | 0.020 |
Why?
| | Polyomaviridae | 1 | 1992 | 1 | 0.020 |
Why?
| | Guidelines as Topic | 1 | 2014 | 264 | 0.020 |
Why?
| | Bird Diseases | 1 | 1992 | 10 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 731 | 0.020 |
Why?
| | Capsid | 1 | 1992 | 90 | 0.020 |
Why?
| | Papillomaviridae | 1 | 1992 | 114 | 0.020 |
Why?
| | Interleukin-12 Receptor beta 2 Subunit | 1 | 2011 | 1 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1202 | 0.020 |
Why?
| | Disulfides | 1 | 2010 | 97 | 0.020 |
Why?
| | Dimerization | 1 | 2010 | 192 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 940 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 10490 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2010 | 265 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2011 | 221 | 0.020 |
Why?
| | Cancer Vaccines | 1 | 2011 | 164 | 0.020 |
Why?
| | Cysteine | 1 | 2010 | 195 | 0.020 |
Why?
| | Autoimmunity | 1 | 2014 | 863 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 1992 | 602 | 0.020 |
Why?
| | Indomethacin | 1 | 2007 | 78 | 0.020 |
Why?
| | Arachidonic Acids | 1 | 2007 | 59 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2007 | 111 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2007 | 80 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 176 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 169 | 0.020 |
Why?
| | Cytosol | 1 | 2007 | 219 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2007 | 813 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 20412 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 313 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2007 | 250 | 0.020 |
Why?
| | Neutrophils | 1 | 2011 | 1210 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 1992 | 1366 | 0.020 |
Why?
| | Antigens, CD1d | 1 | 2005 | 66 | 0.010 |
Why?
| | Child | 1 | 2025 | 20884 | 0.010 |
Why?
| | Muromegalovirus | 1 | 2004 | 21 | 0.010 |
Why?
| | Mycobacterium bovis | 1 | 2004 | 16 | 0.010 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 29 | 0.010 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 44 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2005 | 212 | 0.010 |
Why?
| | Mast-Cell Sarcoma | 1 | 2003 | 6 | 0.010 |
Why?
| | Immunodominant Epitopes | 1 | 2003 | 28 | 0.010 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2004 | 182 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2003 | 202 | 0.010 |
Why?
| | Herpesviridae Infections | 1 | 2004 | 141 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 262 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2003 | 179 | 0.010 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2003 | 186 | 0.010 |
Why?
| | Adult | 1 | 2025 | 35600 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 477 | 0.010 |
Why?
| | Calcium | 1 | 2007 | 1212 | 0.010 |
Why?
| | Microfilament Proteins | 1 | 2001 | 128 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 2001 | 173 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2001 | 335 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1998 | 191 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2003 | 3186 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 6555 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2001 | 3080 | 0.010 |
Why?
| | Peptides | 1 | 1998 | 926 | 0.010 |
Why?
| | Chick Embryo | 1 | 1992 | 130 | 0.010 |
Why?
| | Hybridomas | 1 | 1992 | 235 | 0.010 |
Why?
|
|
Lenz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|